SHPH
Income statement / Annual
Last year (2023), Shuttle Pharmaceuticals Holdings, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Shuttle Pharmaceuticals Holdings, Inc.'s net income was -$6.59 M.
See Shuttle Pharmaceuticals Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$6,811.00 |
$66,832.00 |
$60,834.00 |
$54,951.00 |
$18,000.00 |
$18,739.00 |
| Gross Profit |
-$6,811.00 |
-$66,832.00 |
-$60,834.00 |
-$54,951.00 |
-$18,000.00 |
-$18,739.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$3.52 M
|
$1.49 M
|
$1.02 M
|
$161,772.00
|
$55,572.00
|
-$836.00
|
| General & Administrative
Expenses |
$1.05 M
|
$1.07 M
|
$721,184.00
|
$347,750.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$1.05 M
|
$1.07 M
|
$721,184.00
|
$347,750.00
|
$513,059.00
|
$185,987.00
|
| Other Expenses |
$1.33 M |
$328,687.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$5.89 M |
$2.55 M |
$1.74 M |
$509,522.00 |
$568,632.00 |
$185,151.00 |
| Cost And Expenses |
$5.89 M |
$2.55 M |
$1.74 M |
$509,522.00 |
$586,632.00 |
$203,890.00 |
| Interest Income |
$79,117.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$2.60 M |
$969,889.00 |
$50,788.00 |
$39,630.00 |
$30,916.00 |
$10,881.00 |
| Depreciation &
Amortization |
$6,811.00
|
$5,972.00
|
$60,834.00
|
$54,951.00
|
$18,000.00
|
$18,739.00
|
| EBITDA |
-$3.99 M
|
-$4.32 M
|
-$1.04 M
|
-$711,151.00
|
-$577,223.00
|
-$183,971.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$700,343.00
|
-$474,170.00
|
$590,858.00
|
-$296,210.00
|
-$39,507.00
|
-$9,704.00
|
| Income Before Tax |
-$6.59 M |
-$3.03 M |
-$1.15 M |
-$805,732.00 |
-$626,139.00 |
-$213,594.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$71,009.00 |
$50,788.00 |
$39,630.00 |
$0.00 |
$1.00 |
| Net Income |
-$6.59 M |
-$3.10 M |
-$1.20 M |
-$845,362.00 |
-$626,139.00 |
-$213,594.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.41 |
-0.3 |
-0.0885 |
-0.0622 |
-0.0461 |
-0.0157 |
| EPS Diluted |
-0.41 |
-0.3 |
-0.0885 |
-0.0622 |
-0.0461 |
-0.0157 |
| Weighted Average Shares
Out |
$15.91 M
|
$10.35 M
|
$13.59 M
|
$13.59 M
|
$13.59 M
|
$13.59 M
|
| Weighted Average Shares
Out Diluted |
$15.91 M
|
$10.35 M
|
$13.59 M
|
$13.59 M
|
$13.59 M
|
$13.59 M
|
| Link |
|
|
|
|
|
|
